Kidney failure and heart related death is a risk for Type 1 diabetes patients with kidney dysfunction, researchers said, underlining the need for better treatments.
According to statistics, nearly one-third of Type 1 diabetes patients develop macroalbuminuria, a condition where increased amounts of protein is lost through the urine. Kidney failure and death from heart-related causes is a risk for such patients.
Effective therapies are need of the hour and can go a long way in retarding the advancement to end stage renal disease in Type 1 diabetes patients with macroalbuminuria.
Dr. Andrzej Krolewski, of the Joslin Diabetes Center and Brigham and Women's Hospital in Boston, said, "New therapies need to be developed including more aggressive or experimental protocols to stop or retard declining renal function, which leads to end-stage renal disease."